InsiderDB

Lobbying disclosures · Lobbying report

CRL: third_quarter 2026 lobbying report

Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues surrounding improvements to clinical research capabilities and modernization of research methods.

Follow CRL
Became public
Oct 20, 2026, 9:28 PM EDT
Event / period date
Not stated
Collected
Nov 12, 2026, 12:38 AM EST

Why this is connected

Exact legal-name match: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (https://www.sec.gov/Archives/edgar/data/1100682/).

Reported lobbying amounts

Income: $80,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/36a1de6a-2b2d-45b9-9385-ccc0b9c3a264/","filing_uuid":"36a1de6a-2b2d-45b9-9385-ccc0b9c3a264","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/36a1de6a-2b2d-45b9-9385-ccc0b9c3a264/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tazeen Ahmad","dt_posted":"2026-10-20T21:28:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"926 Pennsylvania Ave, SE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":72053,"url":"https://lda.gov/api/v1/registrants/72053/","house_registrant_id":35843,"name":"CAPITOL HILL CONSULTING GROUP","description":"Government Relations Firm","address_1":"926 Pennsylvania Ave, SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAZEEN AHMAD","contact_telephone":"+1 202-488-0101","dt_updated":"2026-08-17T10:56:59.984637-04:00"},"client":{"id":71107,"url":"https://lda.gov/api/v1/clients/71107/","client_id":71107,"name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC","general_description":"Contract Research Organization","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-09"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61615,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"SUTTER","suffix":null,"suffix_display":null},"covered_position":"Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02","new":false},{"lobbyist":{"id":141629,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"DAVIS","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).","new":false},{"lobbyist":{"id":71228,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"ELIZABETH","last_name":"WILKINSON-HOLLAND","suffix":null,"suffix_display":null},"covered_position":"Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"Issues surrounding improvements to clinical research capabilities and modernization of research methods.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61615,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"SUTTER","suffix":null,"suffix_display":null},"covered_position":"Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02","new":false},{"lobbyist":{"id":141629,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"DAVIS","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).","new":false},{"lobbyist":{"id":71228,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"ELIZABETH","last_name":"WILKINSON-HOLLAND","suffix":null,"suffix_display":null},"covered_position":"Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues surrounding improvements to clinical research capabilities and modernization of research methods.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61615,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"SUTTER","suffix":null,"suffix_display":null},"covered_position":"Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02","new":false},{"lobbyist":{"id":141629,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"DAVIS","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).","new":false},{"lobbyist":{"id":71228,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"ELIZABETH","last_name":"WILKINSON-HOLLAND","suffix":null,"suffix_display":null},"covered_position":"Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in CRL

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.